ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells

Affiliations

• ¹ Centre de recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France; Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix-Marseille Université, Marseille, France; Department of Dermatology, Aix Marseille University, APHM, Hôpital Nord, Marseille, France.
• ² Department of Pathology and INSERM U955 team 9, AP-HP, Hôpital Henri-Mondor, Créteil, France.
• ³ Centre de recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France.
• ⁴ Department of Dermatology, AP-HP, Hôpital Henri-Mondor, Créteil, France.
• ⁵ Department of Hematology, Institut Paoli Calmettes, Marseille, France.
• ⁶ Department of Dermatology, Aix Marseille University, APHM, Hôpital Nord, Marseille, France.
• ⁷ Department of Dermatology and Skin Cancers, Hôpital de la Timone, Aix-Marseille Université, Marseille, France.
• ⁸ Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris University, Inserm, U976, Paris, France.
• ⁹ Paris University, INSERM, UMR-976, Institut de Recherche Saint-Louis, Paris, France.